Genetic and Nongenetic Covariates of Pain Severity in Patients with Adenocarcinoma of the Pancreas: Assessing the Influence of Cytokine Genes

Journal of Pain and Symptom Management

Volumn 38, Issue 6, 2009, Pages 894-902

  Reyes Gibby, Cielito C ^a   Shete, Sanjay ^a   Yennurajalingam, Sriram ^a   Frazier, Marsha ^a   Bruera, Eduardo ^a   Kurzrock, Razelle ^a   Crane, Christopher H ^a   Abbruzzese, James ^a   Evans, Douglas ^a   Spitz, Margaret R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

analgesia; cancer; cytokines; epidemiology; genes; molecular epidemiology; Pain

Indexed keywords

ANALGESIC AGENT; FENTANYL; HYDROMORPHONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; METHADONE; MORPHINE; OXYCODONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CANCER PAIN; CANCER STAGING; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; ETHNICITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA;

ADENOCARCINOMA; AGED; ANALGESICS; CYTOKINES; DRUG UTILIZATION; FALSE POSITIVE REACTIONS; FEMALE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 71249086891     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2009.04.019     Document Type: Article

References (29)

1. Watkins L.R., Wiertelak E.P., Goehler L.E., et al. Characterization of cytokine-induced hyperalgesia. Brain Res 654 (1994) 15-26
2. Watkins L.R., Maier S.F., and Goehler L.E. Cytokine-to-brain communication: a review & analysis of alternative mechanisms. Life Sci 57 (1995) 1011-1026
3. Watkins L.R., Maier S.F., and Goehler L.E. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63 (1995) 289-302
4. Watkins L.R., and Maier S.F. Implications of immune-to-brain communication for sickness and pain. Proc Natl Acad Sci USA 96 (1999) 7710-7713
5. Watkins L.R., Milligan E.D., and Maier S.F. Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv Exp Med Biol 521 (2003) 1-21
6. Watkins L.R., and Maier S.F. Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med 257 (2005) 139-155
7. Oh S.B., Tran P.B., Gillard S.E., et al. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci 21 (2001) 5027-5035
8. Reyes-Gibby C.C., Spitz M., Wu X., et al. Cytokine genes and pain severity in lung cancer: exploring the influence of TNF-{alpha}-308 G/A IL6-174G/C and IL8-251T/A. Cancer Epidemiol Biomarkers Prev 16 (2007) 2745-2751
9. Caraceni A., and Portenoy R.K. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain 82 (1999) 263-274
10. Wettergren L., Bjorkholm M., Axdorph U., and Langius-Eklof A. Determinants of health-related quality of life in long-term survivors of Hodgkin's lymphoma. Qual Life Res 13 (2004) 1369-1379
11. Wei J.T., Dunn R.L., Litwin M.S., Sandler H.M., and Sanda M.G. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56 (2000) 899-905
12. Ware Jr. J., Kosinski M., and Keller S.D. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 34 (1996) 220-233
13. Vilaseca I., Chen A.Y., and Backscheider A.G. Long-term quality of life after total laryngectomy. Head Neck 28 (2006) 313-320
14. National Cancer Institute, Cancer Genome Anatomy Project SNP500 Cancer Database. 2007. Available from: http://snp500cancer.nci.nih.gov.
15. Benedetti C., Brock C., Cleeland C., et al. NCCN practice guidelines for cancer pain. Oncology (Williston Park) 14 (2000) 135-150
16. Wacholder S., Chanock S., Garcia-Closas M., El G.L., and Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96 (2004) 434-442
17. Puthothu B., Krueger M., Heinze J., Forster J., and Heinzmann A. Impact of IL8 and IL8-receptor alpha polymorphisms on the genetics of bronchial asthma and severe RSV infections. Clin Mol Allergy 4 (2006) 2
18. Brisby H., Olmarker K., Larsson K., Nutu M., and Rydevik B. Proinflammatory cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica. Eur Spine J 11 (2002) 62-66
19. Ebrahimi B., Tucker S.L., Li D., Abbruzzese J.L., and Kurzrock R. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer 101 (2004) 2727-2736
20. Cunha T.M., Verri Jr. W.A., Silva J.S., et al. A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci USA 102 (2005) 1755-1760
21. Ribeiro R.A., Vale M.L., Thomazzi S.M., et al. Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol 387 (2000) 111-118
22. Kotani N., Kudo R., Sakurai Y., et al. Cerebrospinal fluid interleukin 8 concentrations and the subsequent development of postherpetic neuralgia. Am J Med 116 (2004) 318-324
23. Bessler H., Shavit Y., Mayburd E., Smirnov G., and Beilin B. Postoperative pain, morphine consumption, and genetic polymorphism of IL-1beta and IL-1 receptor antagonist. Neurosci Lett 404 (2006) 154-158
24. Honore P., Wade C.L., Zhong C., et al. Interleukin-1alphabeta gene-deficient mice show reduced nociceptive sensitivity in models of inflammatory and neuropathic pain but not post-operative pain. Behav Brain Res 167 (2006) 355-364
25. McCulley M.C., Day I.N., and Holmes C. Association between interleukin 1-beta promoter (-511) polymorphism and depressive symptoms in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 124 (2004) 50-53
26. Milligan E.D., Soderquist R.G., Malone S.M., et al. Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain. Neuron Glia Biol 2 (2006) 293-308
27. Milligan E.D., Sloane E.M., Langer S.J., et al. Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain 126 (2006) 294-308
28. Chanock S.J., Manolio T., Boehnke M., et al. Replicating genotype-phenotype associations. Nature 447 (2007) 655-660
29. Reyes-Gibby C.C., Wu X., Spitz M., et al. Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol 9 (2008) 777-785